Pharmacological characterization of a new Ca2+ sensitizer

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 994-1004

  Dorigo, Paola ^a   Floreani, Maura ^a   Santostasi, Giovanni ^a   Maragno, Ildebrando ^a   Danieli Betto, Daniela ^a   Germinario, Elena ^a   Magno, Sebastiano Marciani ^a   Primofiore, Gianpaolo ^b   Marini, Anna Maria ^b   Da Settimo, Federico ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (BETA CHLOROETHYL) 5,11 DIHYDRO 11 METHYL 5 OXOPYRIDO[2',3':4,5]PYRIMIDO[1,2 A]BENZIMIDAZOL 1 IUM BROMIDE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); BENZIMIDAZOLE DERIVATIVE; CAFFEINE; CALCIUM SENSITIZER; CARBACHOL; CETOMACROGOL; CONTRACTILE PROTEIN; INOTROPIC AGENT; MEPYRAMINE; PHOSPHODIESTERASE; PRAZOSIN; PROPRANOLOL; RANITIDINE; RUTHENIUM RED; SULMAZOLE; TROPONIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; GUINEA PIG; HEART ATRIUM MUSCLE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENZIMIDAZOLES; CAFFEINE; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; IMIDAZOLES; MALE; MUSCLE CONTRACTION; MYOCARDIAL CONTRACTION;

EID: 0033679453     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Synthesis of 5,11-dihydro-5-oxopyrido[2',3':4,5]pyrimido[1,2-a]benzimidazoles as potential antitumor agents
2. Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium?
3. 2+ gating of skeletal muscle and cardiac ryanodine receptors
4. Effects of age on sarcoplasmic reticulum properties and histochemical composition of fast- and slow-twitch rat muscles
5. Calcium sensitivity and myofibrillar protein isoforms of rat skinned skeletal muscle fibres
6. A pharmacological, crystallographic, and quantum chemical study of new inotropic agents
7. Origin and mechanism of heart failure in hypertensive patients: Left ventricular remodeling in hypertensive heart disease
8. 2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells
9. Heart failure: A growing public health problem
10. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with endstage heart failure
11. Mechanisms of plumbagin action on guinea pig isolated atria
12. Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance
13. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress
14. 2+ uptake by cardiac membrane vesicles
15. Influence of phosphodiesterase inhibition and carbachol on inotropic effects of P-substituted AMPc analogues
16. Evolving concepts of heart failure: Cooling furnace, malfunctioning pump, enlarging muscle: II: Hypertrophy and dilatation of the failing heart
17. A novel thiadiazinone derivative fully reverses acidosis-induced depression of force in cardiac muscle by a calcium-sensitizing effect
18. Protein measurement with the Folin phenol reagent
19. Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle
20. 15 Years of heart-failure trials - What have we learned
21. Functional nonequality of the cardiac and skeletal ryanodine receptors
22. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum
23. Effects of changes of pH on the contractile function of cardiac muscle
24. 2+-sensitizing property of xanthine oxidase inhibitors
25. Calcium accumulation by sarcoplasmic reticulum in two populations of chemically skinned human muscle fibers
26. 2+ release from sarcoplasmic reticulum of skinned fast- and slow-twitch muscle fibers
27. 2+ in heart cardiac myocytes
28. Cardiac remodeling in congestive heart failure
29. Epidemiology of heart failure and ventricular dysfunction
30. Mechanisms of caffeine activation of single calcium-release channel of sheep cardiac sarcoplasmic reticulum
31. Competitive blockade of α-adrenergic receptors in rat heart by prazosin
32. Equilibrium calcium-calcium exchange in cardiac sarcolemmal vesicles
33. The effects of acidosis on ventricular muscle from adult and neonatal rats
34. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
35. Hydroxylated chloropromazine metabolites: Positive inotropic action and the release of catecholamines
36. Assay of cyclic nucleotide phosphodiesterase with radioactive substrates
37. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: Differences with disuse atrophy as assessed on microbiopsies by a new electrophoretic micromethod
38. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
39. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets
40. Protein kinase A (PKA)-dependent troponin I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy